CClinicalTrials.gg
CompletedNCT00441506Updated Aug 24, 2010

Effects of Daily Interruption of Sedatives in Critically Ill Children

An interventional study of daily interruption of sedatives in Critical Illness, sponsored by Radboud University Medical Center. Completed at 1 site in Netherlands. Open to participants aged Up to 12 Years. Per ClinicalTrials.gov, last updated 2010-08-24.

Sponsored by Radboud University Medical Center · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
Up to 12 Years
Sex
All
01

Study summary

Critically ill children are often sedated in order to relieve them from anxiety and discomfort, and to facilitate their care. There is little information on the effects of prolonged and continuous use of sedatives and analgesic agents in critically ill children. In adult intensive care unit (ICU) patients, daily interruption of sedative infusions accelerates recovery resulting in a reduction in the average duration of mechanical ventilation of 2.4 days as well as a reduction in average ICU length of stay of 3.5 days. These results were achieved without an increased rate of adverse events potentially linked to less sedation and associated with a reduction of common complications of critical illness and without negative psychological effects.

It is unknown whether these results can be extrapolated to critically ill children. Moreover, the possible risk of complications associated with less sedation, such as accidental self-extubation, is probably higher in children. Also, the need for intermittent bolus administrations in children treated with intermittent sedation could nullify the reduction in the use of sedatives.

It is unknown if daily interruption of sedatives is feasible in critically ill children. The researchers studied the effects of daily interruption of sedatives in critically ill children on the total amount of sedatives used and risks of complications.

02

Conditions studied

  • Critical Illness

Browse trials for

Keywords

  • interruption
  • critically ill
  • sedation
  • pediatrics
  • critically ill, ventilated children
03

In context

Critical Illness

1,881 studies on the registry are indexed under Critical Illness; 462 are open to participants now.

This study's enrollment of 30 is below the median of 90 across 979 interventional studies indexed under Critical Illness.

Browse Critical Illness studies →

Lead sponsor

Radboud University Medical Center is the lead sponsor of 959 studies on the registry; 134 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Intubated and mechanically ventilated for > 24 hours
  • Expect further mechanical ventilation for > 48 hours
  • Receiving midazolam and morphine for sedation
  • Written informed consent given by parents

Exclusion Criteria:

  • Inclusion in another trial
  • Transfer from an outside institution where sedatives had been administered
  • Neuromuscular blockers
  • Metabolic disease
  • Neuromuscular disease
  • Encephalopathy
  • Epilepsy
  • Pulmonary hypertension
  • Neurotrauma
  • Raised intracranial pressure
  • Life expectancy less than a month/infaust prognosis
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (actual)

Interventions

  • Drugdaily interruption of sedatives
06

What researchers measure

Primary outcomes

  1. amount of (near) incidents

    Time frame: Until extubation or 28 days

  2. total amount of sedatives administered

    Time frame: Until extubation or 28 days

  3. time to wake up (after sedation is stopped), comfort scale

    Time frame: Until extubation or 28 days

  4. BIS monitoring

    Time frame: Until extubation or 28 days

Secondary outcomes

  1. time on ventilator

    Time frame: Until extubation or 28 days

  2. LOS on ICU

    Time frame: Until extubation or 28 days

07

Study locations

1 site
  • Radboud University Nijmegen Medical Center
    Nijmegen, Gelderland 6500HB, Netherlands
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 24, 2010, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00441506
Lead sponsor
Radboud University Medical Center
First posted
Mar 1, 2007
Start date
Nov 2004
Primary completion
Jun 2006
Completion
Jul 2006
Last update
Aug 24, 2010

Study contacts

Peter Pickkers, MD, PhD
study director · Radboud University Medical Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2007. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion